Skip to content
Home › 13F recaps › Q3 2026 › REGN

Which funds bought or sold REGN in Q3 2026?

Regeneron Pharmaceuticals. 11 funds bought, 8 sold, out of 109 tracked funds that have filed for Q3 2026. Among active managers, the estimated net flow was −$195M.

Holdings as of Sep 30, 2026 (Q3 2026)13F deadline Nov 16, 2026 (45 days after quarter end)

PostLinkedIn
Who bought and who sold REGN, by estimated dollars
◀ SoldBought ▶

Top 10 each side. NEW = opened a position, OUT = sold the whole position.

Bought (11)

FundChangeEst. $Now
Citadel
Quant & multi-strategy
Added+512.3%+$224M$267M
Two Sigma
Quant & multi-strategy
Added+32.5%+$162M$659M
Marshall Wace
Quant & multi-strategy
Added+830.2%+$145M$162M
Point72
Quant & multi-strategy
New+$94M$94M
Renaissance
Quant & multi-strategy
Added+83.7%+$94M$206M
Northern Trust
Bank & broker
Added+8.9%+$62M$756M
Bridgewater
Hedge fund
Added+106.4%+$41M$80M
ExodusPoint
Quant & multi-strategy
New+$29M$29M
Tudor
Hedge fund
New+$29M$29M
Maverick
Hedge fund
New+$1M$1M
Pzena
Value investor
New+$310K$310K

Sold (8)

FundChangeEst. $Now
Goldman Sachs
Bank & broker
Trimmed-40.3%−$356M$526M
JPMorgan
Bank & broker
Trimmed-12.4%−$350M$2.5B
Invesco
Asset manager
Trimmed-5.6%−$166M$2.8B
Man Group
Quant & multi-strategy
Trimmed-32.5%−$108M$224M
Susquehanna
Quant & multi-strategy
Trimmed-45.3%−$62M$75M
Adage
Hedge fund
Trimmed-72.9%−$46M$17M
Legal & General
Asset manager
Trimmed-7.8%−$45M$531M
Southeastern
Value investor
Trimmed-8%−$9M$106M

Source: SEC EDGAR Form 13F-HR for each fund, holdings as of Sep 30, 2026. Shares only (options excluded). Estimated $ = change in shares × quarter-end price. Funds may have traded since. Methodology. Not investment advice.

Most bought in Q3 2026 → · Most sold →

Weekly digest · free

13F filings and guru moves, in one short email

A Sunday digest of what famous investors said and filed this week, plus an alert when someone changes stance. Free, no spam, unsubscribe anytime.